Obama to OK embryonic stem cell research

WorldNetDaily reports – In a closed-door meeting with House Democrats at their retreat at the posh Kingsmill Golf Resort in Williamsburg, Va., President Obama gave his “guarantee” he will sign an executive order overturning President Bush’s executive order restricting federal funding for embryonic stem cell research. Obama’s reversal of Bush’s policy comes in the face of scientific evidence that more than two decades of embryonic stem cell research have failed to produce medically valuable results, while adult stem cell research has resulted in successful medical treatments for a wide range of illnesses. By using an executive order to approve embryonic stem cell research for human therapeutic uses, the Obama administration plans to bypass congressional discussion and debate, seeking instead to reverse the Bush executive order without introducing any new legislation, the Washington Times reports. Obama appears determined to push the embryonic stem cell political agenda, despite medical concerns that therapeutic results in human medical treatments over decades have proved that adult stem cells and stem cells derived from human placenta produce results, while embryonic stem cells produce tumors hazardous to human health. “Most of the media report only ’stem cell’ research, not distinguishing between embryonic stem cells and adult stem cells,” David Prentice, senior fellow for life sciences at the Family Research Council, told WND.

Ed. It can be exhausting (and certainly is a never-ending task) to have to endlessly expose and comment on such articles as this. I wish someone would explain to me why the American press consistently fails to publish the fact that Adult Stem Cells are helping thousands of sufferers right now – safely and effectively. All that Embryonic Stem Cells have done so far is produce tumors in rats. I doubt we will ever see the day that a clinical trial of embryonic cells actually starts with human subjects. Scientists are too wary of them. But their lobby is powerful and the U.S. taxpayer seems happy to fork out their money for them.